Latanoprost - Glaucoma / ocular hypertension
You are here : Home > Formulary Search > Latanoprost - Glaucoma / ocular hypertension
Status 1
- Eye drops
- Eye drops (preservative free
- unit dose)
Documentation
PAD Profile
Other Indications
Below are listed other indications that Latanoprost is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Glaucoma / ocular hypertension.
- Acetazolamide
- Apraclonidine
- Betaxolol
- Bimatoprost
- Bimatoprost with timolol
- Brimonidine tartrate
- Brimonidine with timolol
- Brinzolamide
- Brinzolamide with brimonidine
- Brinzolamide with timolol
- Dorzolamide
- Dorzolamide with timolol
- Latanoprost with netarsudil
- Latanoprost with timolol
- Levobunolol hydrochloride
- Pilocarpine hydrochloride
- Tafluprost
- Timolol
- Travoprost
- Travoprost with timolol
Committee Recommendations (3)
UPON SPECIALIST RECOMMENDATION ONLY
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Primary care prescribers do not have the necessary equipment or skills to perform ocular pressure readings to make a diagnosis. The APC recomments that this product, when used for treatment of glaucoma, should be considered as BLUE.
Note; the branded product (Xalatan) was considered as BLACK at the PCN in May 2017.
Pending the imminent patent expiry of Xalatan, generic latanoprost will be the most cost effective prostaglandin analogue in primary and secondary care. Acute trust colleagues are requested to initiate patients on generic latanoprost as the first line prostaglandin analogue. Xalatan prescribing in primary care should be changed to generic.